PMA P100018S043

Device
Pipeline™ Vantage Embolization Device with Shield Technology™
Applicant
Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
PMA number
P100018
Supplement
S043
Product code
OUT
Decision date
2024-06-06
Classification
Neurology
Generic name
Intracranial aneurysm flow diverter
Approval order statement
approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P100018/S034

Current openFDA PMA Record#

Device
Pipeline™ Vantage Embolization Device with Shield Technology™
Applicant
Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
PMA number
P100018
Supplement
S043
Product code
OUT
Generic name
Intracranial aneurysm flow diverter
Decision date
2024-06-06
Decision code
APPR
Date received
2023-10-13
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Approval order statement
approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P100018/S034